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During vertebrate embryogenesis, the somites form by segmentation of the trunk mesoderm, lateral to the neural tube, in an anterior to
posterior direction. Analysis of differential gene expression during somitogenesis has been problematic due to the limited amount of tissue
available from early mouse embryos. To circumvent these problems, we developed a modified differential display PCR technique that is
highly sensitive and yields products that can be used directly as in situ hybridisation probes. Using this technique, we isolated NLRR-1 as a
gene expressed in the myotome of developing somites but not in the presomitic mesoderm. Detailed expression analysis showed that this
gene was expressed in the skeletal muscle precursors of the myotome, branchial arches and limbs as well as in the developing nervous
system. Somitic expression occurs in the earliest myoblasts that originate from the dorsal lip in a pattern reminiscent of the muscle
determination gene Myf5, but not at the ventral lip, indicating that NLRR-1 is expressed in a subset of myotome cells. The NLRR genes
comprise a three-gene family encoding glycosylated transmembrane proteins with external leucine-rich repeats, a fibronectin domain, an
immunoglobulin domain and short intracellular tails capable of mediating protein–protein interaction. Analysis of NLRR-3 expression
revealed regulated expression in the neural system in developing ganglia and motor neurons. NLRR-2 expression appears to be predominately
confined to the adult. The regulated embryonic expression and cellular location of these proteins suggest important roles during mouse
development in the control of cell adhesion, movement or signalling.
D 2005 Elsevier Inc. All rights reserved.
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Proteos, Singapore 138673, Singapore.neural tube, form sequentially from the anterior end of
the presomitic mesoderm (PSM) such that the most
cranial pair is the first to be born (reviewed by Tam
and Trainor, 1994). The birth of each somite involves the
allocation of progenitor cells to each segment, the
formation of the border between adjacent segments and
a mesenchymal to epithelial transition (Kulesa and Fraser,
2002). Together, these processes give rise to a somite
which is clearly separated from both the PSM and the
preceding somite, and which is comprised of an epithelial
sphere of cells.
The rhythmic production of pairs of somites depends on
the segmentation clock which was recognised through the281 (2005) 145–159
B.P. Haines et al. / Developmental Biology 281 (2005) 145–159146cyclic expression of genes encoding components of the
Notch signalling pathway (reviewed by Pourquie, 2003).
In the mouse, a Wnt-based negative regulatory loop
appears to entrain a series of Notch-based loops (Aulehla
et al., 2003). Fgf8 signalling plays a key role in translating
the output of the clock into the periodic arrangement of
segment boundaries and recent evidence implicates Wnt
signalling in this process (Aulehla et al., 2003; Dubrulle et
al., 2001; Sawada et al., 2001). The first overt sign of
segmentation is the expression of the gene encoding the
transcription factor Mesp2 in a one somite wide stripe. The
proteins of this family act upstream of the Notch pathway
which controls the positioning of the boundaries and the
formation of the anterior and posterior somitic compart-
ments (Jen et al., 1999; Takahashi et al., 2000). This latter
event involves another bHLH transcription factor, paraxis,
which is also required for somite epithelialisation (Johnson
et al., 2001). There is a clear connection between the
segmentation clock and the activation of the transcription
of the Hox genes (Dubrulle et al., 2001; Zakany et al.,
2001), the products of which act in a combinatorial fashion
to determine segment identity.
In the mouse, the newly born epithelial somite is a
transitory structure. It undergoes a rapid epithelial to
mesenchymal transition whereby cells in the ventral half
give rise to the sclerotome, which contains the precursors
of the axial skeleton. The remaining epithelial sheet, the
dermomyotome, gives rise to skeletal muscle precursors,
which migrate under the epithelium at its dorso-medial
and ventro-lateral lips, to form the myotome, the source
of all trunk muscles. At appropriate levels, cells migrate
away from the ventro-lateral lip to form the limb
muscles. The cells that remain in the dermomyotome
are precursors of the dermis. The recently recognised
fourth compartment of the somite, the syndetome, is
located between the sclerotome and the myotome and
contains the precursors of the axial tendons (Brent et al.,
2003).
We are specifically interested in two aspects of
somitogenesis, the mechanisms involved in the specifica-
tion and differentiation of skeletal muscle precursors
(Teboul et al., 2002) and the regulation of Hox gene
expression and its role in the determination of segmental
identity (Brend et al., 2003). A great deal is known about
the transcriptional cascade, mediated primarily by the
myogenic regulatory factors, that controls skeletal myo-
genesis (reviewed by Buckingham, 2001). Key tran-
scription factors that operate in the other somitic
compartments have also been identified, e.g., Pax1 and
Pax9 in the sclerotome (Rodrigo et al., 2003), Dermo-1
in the skin precursors (Li et al., 1995) and Scleraxis in
the syndetome (Schweitzer et al., 2001). Signalling
pathways that instruct the fate of cells in the various
somitic compartments are well characterised, e.g., sonic
hedgehog in the sclerotome (Buttitta et al., 2003), Wnts
and BMP4 in the myotome (Buckingham, 2001) andFGFs in the syndetome (Brent et al., 2003). However, we
know relatively little about subsequent events in myo-
genesis, about how cells move out of the dermomyotome,
how they migrate or about muscle morphogenesis.
Similarly, while much work has been done to unravel
the complexities of Hox gene regulation (reviewed by
Kmita and Duboule, 2003), we have a limited under-
standing of how these transcription factors impose
segmental identity because target genes have not been
identified.
It would therefore be extremely useful to have a method
that allowed the identification of genes expressed at
particular stages of somitogenesis so that we could find
candidate downstream effectors of the well characterised
transcriptional regulators. Such a method should be highly
sensitive, so that one could, for example, compare one
somite pair with an adjacent pair, and should therefore be
capable of analysing very small amounts of mRNA,
without the need for cDNA library construction. It should
not depend, as do methods like SAGE, on high throughput
sequencing capacity which is not available in most
developmental biology laboratories. Most importantly, it
should lead rapidly to the generation of probes suitable for
whole-mount in situ hybridisation, so that the expression
pattern of the gene in question can be visualised rapidly in
the context of the three-dimensional structure of the
embryo.
We have previously explored the use of differential
display for this general purpose (Gupta et al., 1998) and
encountered significant difficulties. Most notably, each
differential display band contained multiple sequences,
and the DNA fragments were generally too small to
generate effective in situ hybridisation probes. We now
show that by combining differential display with the
related technique of arbitrarily primed PCR, these prob-
lems can be overcome. The procedure works on small
amounts of mRNA from dissected embryonic tissues,
each band contains a single sequence, and the fragments
are large enough to generate useful probes. We demon-
strate the utility of the procedure by isolating six
differentially displayed genes and confirming their expres-
sion by in situ hybridisation. One of these genes, the gene
encoding neuronal leucine-rich repeat-1 (NLRR-1) pro-
tein, which is displayed in the somites but not in the
PSM, shows an interesting expression pattern that is
similar to that of the muscle determination gene Myf5.
The NLRRs are encoded by a three-gene family in
mammals. They are glycosylated, transmembrane proteins
which are likely to play a role at the cell surface in
signalling, migration or morphogenesis. NLRR-1 is
expressed in the myotome soon after its formation, and
in the myoblasts of the branchial arches, the hypoglossal
chord and the limbs, in addition to its previously
documented expression in the nervous system. The
expression pattern of NLRR-1 suggests that it plays a
role in early myogenesis.
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Isolation of RNA from dissected tissues
Mouse embryos at somite stage (ss) 10–16 (Sporle and
Schughart, 1997) were obtained from naturally mated
C57BL/6xCBA mice. All dissections were performed in
ice-cold PBS over a 90-min period, using a tungsten needle.
Only one side of each embryo was dissected. An entire
presomitic mesoderm and the corresponding somites II to
IV and V to VII (with somite I defined as being the first
somite with a visible caudal margin) were removed. Total
RNA was prepared by the acid-guanidinium-phenol method
(Chomczynski and Sacchi, 1987). 1–25 of each structure
were lysed in 500 Al denaturing solution. Poly A+ selection
was performed with Oligotex-dTk latex beads (Qiagen)
following the manufacturer’s instructions.
RT-PCR
Reverse transcription (RT) was performed on poly A+
enriched RNA obtained from an equivalent of 5 presomitic
mesoderms or somites using 1 AM dT24 in a 20-Al
reaction containing 100 units of Superscriptk reverse
transcriptase (Invitrogen). 2.5 Al of each RT reaction was
used as a template for PCR using each of the following
primer pairs; HPRT, 5V-CCTGCTGGATTACATTAAAG-
CACTG and 5V-GTCAAGGGCATATCCAACAACAAAC;
Oct3 , 5V-GGCCTCGAAGCGACAGATGG and 5V-
CAGGCCCCCGGCTCGGGGTGCC; Myf5 , 5V-AAG-
GATCCTGAGGGAACAGGTGGAGAAC a n d
5VAAGGATCCAAGCTGGACACGGAGTTTTTATC;
Dll3, 5V-CTTGGGGCTGCTGGTGGCCGCCGG and 5V-
CCCTTTCAAAGAGTCTCCAGTCGG; Myogenin 5V-
CCAGTTGGTGTCAAAAGCC and 5V-CTCTCTG-
CTTTAAGGAGTCAG. The reaction parameters were 35
cycles of 958C for 30 s, 558C for 20 s and 738C for 30 s.
Differential display PCR
2.5 Al of each RT reaction was used as a template in 20-
Al reactions containing 2 units of AmpliTaqR DNA
polymerase (Perkin-Elmer), 10 mM Tris–HCl pH 8.3, 50
mM KCl, 1.6 mM MgCl2, 2.5 AM each dNTP, 0.5 AM
arbitrary 24mer (5V-GATTGTCGGGATCCGATCTGACAC
used in Fig. 2) and 2.5 ACi (75 nM) [a33P] dATP. The
reactions were performed with the parameters 948C for 90 s;
2 cycles of 948C for 30 s, 408C for 180 s, 738C for 90 s; 40
cycles of 948C for 30 s, 608C for 60 s, 738C for 90 s. The
resulting products were separated by native polyacrylamide
gel electrophoresis. Gels were dried and exposed to auto-
radiographic film. Bands were excised and eluted in 100 Al
sterilised water for 4 h and 5 Al reamplified using the
appropriate primers in 40 Al PCR reactions for 35 cycles of
958C for 30 s, 608C for 30 s and 738C for 60 s. Reamplified
bands were end-polished with Pfu polymerase (Stratagene)and cloned into EcoRV digested pBluescript II KS
(Stratagene). Six clones were picked per band and
sequenced using an ABI PRISMk 377 DNA Sequencer
(Perkin Elmer).
NLRR cDNAs
Full-length cDNAs for NLRR-1 and NLRR-3 have been
described previously (Taguchi et al., 1996; Taniguchi et al.,
1996). cDNAs for NLRR-2 have been cloned by us
(GenBank accession no. AY362823) and others
(NM_010732, BC056458). A cDNA (XNLRR-B) encoding
bases 643 to 1387 of Xenopus NLRR-1 sequence (Hayata et
al., 1998) was isolated by RT-PCR from stage 30 Xenopus
embryo mRNA with primers 5V-CTTCTCTGGGCT-
GCGTAATC and 5V-TACAGGTTGCCCACGGTACT.
Products were cloned into EcoRV digested pBluescript II
KS.
Protein sequence alignments were performed using
ClustalW and annotated using Boxshade available at
www.ch.embnet.org.
In situ hybridisation
In situ hybridisation was performed as described by
Teboul et al. (2002) using the InsituPro in situ hybrid-
isation processor (Intavis AG). Hybridisations were carried
out at 698C. Antisense digoxygenin-labelled riboprobes
were generated using 10 digoxygenin RNA labelling mix
(Roche). A probe for NLRR-1 was transcribed with T7
RNA polymerase from the NLRR-1 differential display
clone linearised with HindIII. An NLRR-3 probe was
transcribed with T3 RNA polymerase from LR3 HIII/RI A,
a plasmid constructed by digesting the NLRR-3 cDNA with
EcoRI and HindIII and ligating the most 5V 689 bp into
pBluescript II KS, which was linearised with EcoRI.
NLRR-2 probes were transcribed from pBluescript-based
plasmids NLRR-2 Sma, containing NLRR-2 cDNA from
the PstI site at 1484 to the SmaI site at 2072, and NLRR-2
Pml, containing sequence from the 3V end of the NLRR-2
cDNA to the PmlI site at 2433 bp. Both plasmids were
linearised with EcoRI and transcribed with T7 RNA
polymerase. A Xenopus NLRR-1 riboprobe was transcribed
from XNLRR-B digested with HindIII using T3 polymer-
ase. Embryos were sectioned by embedding in agarose and
cutting 70-Am sections using a vibratome.
Northern analysis
Mouse MTN filters (Clontech) containing adult mouse
RNAs were probed with NLRR cDNAs using ExpressHyb
hybridisation solution following the manufacturer’s instruc-
tions. Probes were synthesised with 5 Al of [a32P] dCTP
(Amersham) using the Radprime labelling kit (Invitrogen)
following the manufacturer’s instructions and purified using
Sephadex G50.
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NLRR protein was analysed by transfecting C-terminal
FLAG-tagged NLRR cDNAs in the expression vector
pCDNA3.1 into Cos-7 cells using Fugene 6 transfection
reagent (Roche). For immunofluorescence, cells were plated
onto coverslips in 6-cm dishes. 48 h post transfection, cells
were fixed with methanol, rehydrated in PBS and stained
using anti-FLAG M2 monoclonal antibody (Sigma), follow-
ing the manufacturer’s instructions, and concanavalin A
(Molecular Probes). For Western blot analysis, cells were
plated in 6-cm dishes. 24 h post transfection, cells were
changed into fresh medium or medium containing 8 Ag/ml
tunicamycin (Sigma) and lysed 48 h post transfection by
resuspension in 100 Al 1 SDS-PAGE gel loading buffer
and heating at 1008C for 10 min. Protein extracts were
separated by SDS-PAGE and transferred to nylon mem-
brane. Blots were probed with anti-FLAG M2 monoclonal
antibody (Sigma) following the manufacturer’s instructions.
Blots were visualised using ECL Western blotting detection
reagents (Amersham).Results
Differential display analysis of somites and presomitic
mesoderm
To isolate genes uniquely expressed in somites or
presomitic mesoderm, we dissected these tissues from
mouse embryos at ss 10–20 (Fig. 1). Due to the laborious
dissections required to isolate tissues free of extraneous
contamination and the minute amounts of tissue obtained
from these dissections, we used modified mRNA differential
display PCR to analyse genes differentially expressed
between these tissues. This strategy is useful as it can be
performed with nanogram quantities of starting mRNA.Fig. 1. Modified differential display PCR of somites and presomitic mesoderm. An
and presomitic mesoderm (B). mRNA was isolated and marker gene expression
SOM—somite; HPRT—hypoxanthine guanine phosphoribosyl transferase; MyoG—
and somitic (S) mRNA using a single random primer. A differentially expressed
markers are shown in base pairs.The accuracy of the dissections and the integrity of the
mRNA from these dissected tissues were confirmed using
RT-PCR with oligonucleotide primers specific for marker
genes known to be differentially expressed in somites and
presomitic mesoderm. In each case, primer pairs were
designed to sequences located in different exons and single
PCR bands specific for each cDNAwere detected (Fig. 1B).
From in situ hybridisation analysis of ss 10–16 mouse
embryos, we would expect to detect HPRT (Melton et al.,
1986) and Oct3 (Rosner et al., 1990) in both somites and
presomitic mesoderm. Myf5 can be detected in both tissues
by RT-PCR (Kopan et al., 1994) but only in somites by in
situ hybridisation (Summerbell et al., 2000) and was found
in presomitic mesoderm and somites. Myogenin is
expressed only in more mature somites by in situ hybrid-
isation (Sassoon et al., 1989) while Delta-like 3 (Dll3) is
expressed predominantly in the presomitic mesoderm with a
weak in situ hybridisation signal in the nascent somites
(Dunwoodie et al., 1997). RT-PCR analyses of myogenin
and Dll3 showed signals in the expected tissues. These data
confirmed the reliability and accuracy of our dissection and
mRNA isolation procedures.
The limited tissue availability from mouse embryos and
the wealth of data obtainable per experiment make whole-
mount in situ hybridisation the secondary screen of choice.
We have previously found that conventional differential
display using arbitrary 10mers and a polyT primer produces
clones which are generally too small (mean size 200–300
bp) to reliably provide probes suitable for in situ hybrid-
isation (Gupta et al., 1998). To increase the mean size of the
clones that we could obtain, we combined the related
technique of arbitrarily primed PCR RNA fingerprinting
with differential display PCR (Diachenko et al., 1996;
Welsh et al., 1992), using an arbitrary 24mer as primer,
omitting the polyT primer, and 2 cycles of low annealing
stringency amplification followed by 40 cycles at high
stringency (see Materials and methods). Using this protocol,ss10 mouse embryo (A) was dissected yielding somites II to IVand V to VII
was analysed by non-quantitative RT-PCR. PSM—presomitic mesoderm;
myogenin; Dll3—delta-like 3. (C) ddPCR gel of presomitic mesoderm (P)
band corresponding to NLRR-1 is indicated by the arrow. Sizes of DNA
Fig. 2. Genes isolated from differential display PCR between presomitic
mesoderm and somites. (A–D) Whole-mount in situ hybridisation of
9.5–10.5 dpc mouse embryos using riboprobes transcribed from
differential display PCR fragments. (A) connexin43. (B) reticulon 1.
(C) thioredoxin domain containing 5. (D) neuronal leucine-rich repeat-
1. i and ii are sections of the embryos in A–D. The plane of section is
indicated by white lines. Cii is an enlargement of the region of the
embryo indicated by the bracket. Numbers in A–D indicate days post
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length (Fig. 1C) with fewer bands per gel compared to
standard differential display performed with 10mers corre-
sponding to the ten most 3V bases of the arbitrary 24mer
used here (data not shown). We also found that only a single
DNA fragment was present in each band compared to
conventional differential display where several different
clones of identical size are often isolated from a single band
(Gupta et al., 1998).
We performed preliminary experiments with several
different primers and isolated a total of six genes that were
differentially displayed between somites and presomitic
mesoderm (Table 1). In experiments using standard differ-
ential display PCR, we found approximately one in ten
differential display products yielded useful in situ hybrid-
isation probes. Using this method, we found approximately
half the isolated differential display fragments produced
useful riboprobes. This improvement makes tenable the use
of this modified differential display PCR protocol in
combination with in situ hybridisation as a method for the
identification and analysis of genes differentially expressed
between two embryonic tissues of limiting quantity.
Using this technique, we identified Sp5, which has
previously been shown by in situ hybridisation to be
strongly expressed in presomitic mesoderm but not in early
somites (Harrison et al., 2000), as a transcript differentially
displayed in presomitic mesoderm. We also identified
connexin43 (Cx43) as a gene expressed throughout the
presomitic mesoderm, a site of expression that had not
previously been described (Fig. 2A). This expression
restricts to the tail bud as the embryo develops in addition
to previously described expression in the limb bud and
neural crest cells (Lo et al., 1997; Ruangvoravat and Lo,
1992). Dynein intermediate chain 1 (Dnci1) was differ-
entially displayed in somites but expressed in dorsal root
ganglia by in situ hybridisation as previously described
(Crackower et al., 1999). Reticulon 1 was also differentially
displayed in somites but expressed in dorsal root ganglia
(Fig. 2B). This is consistent with dorsal root ganglia
migrating through early, caudal somites where they are not
clearly discernable from somitic tissue, before they form the
distinct cell groups present between the neural tube and
more mature, rostral somites (Fig 2Bi). Thus, somitogenesis
is a good model for analysis of gene expression by in situTable 1
Summary of genes isolated from differential display PCR experiments and
their expression patterns as determined by in situ hybridisation
ddPCR Gene In situ expression
psm Sp5 Presomitic mesoderm
psm Connexin43 Presomitic mesoderm
Somite Thioredoxin domain
containing 5 (Txndc5)
Somite (dermomyotome)
Somite Dynein intermediate chain 1 Dorsal root ganglia
Somite Neuronal leucine-rich
repeat-1 (NLRR-1)
Somite (myotome)
Somite Reticulon 1 Dorsal root ganglia
coitum. nt—neural tube, psm—presomitic mesoderm, drg—dorsal root
ganglia, mn—motor neurons, tg—trigeminal ganglia, fp—floor plate,
m—myotome, dm—dermomyotome.hybridisation because a panel of somites of different
developmental stages can be analysed in a single embryo.
These data indicate that the limitations in this type of study
are at the level of the dissection. Interestingly, reticulon 1
was also found in a specific subset of neurons in the
midbrain (Fig. 2Bii, arrowhead). Thioredoxin domain
containing 5 (Txndc5) was expressed at low levels in early
somites but not presomitic mesoderm (Figs. 2C and Cii)
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technique. This expression could be more easily identified
in sections where expression was localised to a thin layer of
cells at the inner edge of the dermomyotome (Fig. 2Ci,
arrowhead). Finally, neuronal leucine-rich repeat 1 (NLRR-
1) was differentially expressed in somites but not presomitic
mesoderm (Fig. 2A) which was confirmed by in situ
hybridisation (Fig. 2D). Transverse and longitudinal sec-
tions through the somites showed that somitic NLRR-1
expression was specifically restricted to the myogenic
precursors of the myotome but not the dermomyotome
(Figs. 2Di and ii), with expression extending to the dorsal
and ventral extremities of the myotome in mature somites
(Fig. 2Di). Expression was also detected in the myogenic
precursors in the branchial arches and hypoglossal chord,
and also in non-muscle cells in the eye (Fig. 2D). This is in
addition to previously reported expression in the forebrain,
hindbrain and neural tube (Fig. 2B, Taguchi et al., 1996).
Interestingly, neural expression extended throughout the
neural tube with high levels of expression dorsally
surrounding the floor plate (Fig. 2Di). In this study, we
only analysed a limited number of differential display PCR
products in order to show that the technique is suitable for
the isolation of differential cDNAs from tissues of limiting
quantity, and that those cDNAs are of a size that yields
useful templates for probes for whole-mount in situ
hybridisation.
NLRR-1 is expressed in a subset of myogenic precursors
during somite development
NLRR-1 was previously cloned from a neonatal mouse
brain library and its expression localised to the embryonic
and adult nervous system (Taguchi et al., 1996). It has
subsequently been shown that NLRR-1 is expressed in
somites in the mouse (Aubert et al., 2003) and the
dermomyotome and myotome in the chick (Tonegawa et
al., 2003). We here show that somitic expression in the
mouse is restricted to the muscle precursors of the myotome.
To analyse NLRR-1 expression in more detail during
somite development, we performed whole-mount in situ
hybridisation on 9.5 dpc embryos (Fig. 3A). Somitic
expression was first seen in the dorsal lip of the myotome
where myoblasts initially arise (Figs. 3Ai and G). As the
myotome developed NLRR-1 expression extended ventrally,
at first along the anterior side and eventually along the entire
width of the somite (Figs. 3Ai–iv and G). This pattern of
expression coincides with the ventral migration of the
earliest myoblasts from the dorsal lip of the somite into the
myotome. Comparison with the expression of the myogenic
regulatory factors Myf5 and Mrf4 in somite stage matched
embryos showed that the onset of NLRR-1 expression in the
dorsal somitic lip is concurrent with or before that of Myf5
but precedes Mrf4 by 6–12 h (Figs. 3G–H). Unlike Myf5
and Mrf4, no NLRR-1 expression was seen initiating at the
ventral lip of the somite where a later epithelial tomesenchymal transition takes place (Fig. 3G). Expression
was again seen in the migrating myoblasts in the branchial
arches and hypoglossal chord (Fig. 3C, arrowheads), and in
non-muscle cells of the optic stalk (Fig. 3A). In the
developing nervous system, strong NLRR-1 expression
occurred in the forebrain and ventrally in the hindbrain
but was notably absent from the midbrain (Fig. 3A). A
longitudinal dissection through the head showed expression
was restricted to a strong ventral domain in the basal part of
the hindbrain that had a sharp posterior boundary (Fig. 3B,
arrowhead). Further stripes of expression extended dorsally
from this region along the rhombomere boundaries (Fig. 3B,
brackets). Sections through the anterior neural tube revealed
strong expression restricted to a ventral domain close to the
floor plate, consistent with expression in motor neurons,
with weaker expression spreading dorsally (Figs. 3Aiii–v).
Expression was relatively low in the posterior spinal cord
(Figs. 3Ai–ii). NLRR-1 expression was also present in the
myoblasts that will form the muscles of the limb (Fig. 3D,
arrows), and in the hand plate mesenchyme (Fig. 3D,
arrowhead). Analysis of 8 dpc mouse embryos shows
NLRR-1 is expressed dorsally in the early somites and in
two domains in the regions of the neural plate that form the
brain (Fig. 4E). At 9 dpc, expression is again present in the
dorsal region of the developing somites (Fig. 4F). Hindbrain
expression occurs in two distinct domains, forebrain
expression is restricted to a band across the dorsal forebrain
and expression is present in the developing eye.
The Xenopus homologue of NLRR-1 (XNLRR-1) has
been shown to be expressed in the hindbrain, neural tube
and eye at embryonic stage 20 (Hayata et al., 1998). We
analysed Xenopus embryos throughout development for
XNLRR-1 expression. Earliest expression was seen in a
region lateral to the anterior neural plate either side of the
midline (Fig. 4A). As the embryo developed, expression
expanded along the neural tube but was still strongest at the
anterior end (Figs. 4B, C). At stage 20, expression became
apparent in the developing brain and eye which had
intensified by stage 22 (Figs. 4D, E). Expression was also
seen at this stage in the developing somites. By stages 26
and 30, strong expression was seen in the somites and brain
expression became compartmentalised (Figs. 4F, G).
Expression in the neural tube, brain, eye and somites
strongly correlates with sites of expression in the mouse.
The NLRR gene family
To examine the relationship between different members
of the NLRR gene family in the mouse, we compared the
deduced amino acid sequences of NLRR-1, -2 and -3 (Figs.
5 and 6C). These proteins contain a signal sequence for
targeting to the cellular secretory machinery, 12 extracellular
leucine-rich repeats surrounded by C-terminal and N-
terminal cysteine-rich flanking sequences, one fibronectin
type III domain and one immunoglobulin-like C2 domain,
and a predicted transmembrane domain (Fig. 5) suggesting
Fig. 3. NLRR-1 is expressed in myogenic precursors during mouse development. (A) Whole-mount in situ hybridisation of a 9.5 dpc mouse embryo with a
riboprobe for NLRR-1. Sections i–v are transverse sections from the posterior to the anterior end of the embryo with the approximate position shown by yellow
lines. (B) A longitudinal bisection of the head. The arrowhead indicates the sharp boundary of ventral NLRR-1 expression. r—rhombomeres. (C) Bright field
image of a higher magnification of expression in the branchial arches and hypoglossal chord. Expression in the muscle precursors is indicated by the
arrowheads. (D) In situ hybridisation of an isolated forelimb from an 11.5 dpc mouse embryo with a riboprobe for NLRR-1. mp—muscle precursors.
Expression in the hand plate mesenchyme is indicated by the arrowhead. (E) Dorsal view of expression in an 8 dpc mouse embryo. Expression in the somites is
indicated by arrows, expression in the brain by the arrowhead. (F) Expression in a 9 dpc mouse embryo. Numbers at bottom right of A, E and F indicate days
post coitum. (G, H, I) Higher magnification of expression of NLRR-1, Myf5 and Mrf4 in developing somites of somite stage 24 mouse embryos. Red arrows
indicate somite 6 and show ventral Myf5 and Mrf4 expression where there is no corresponding NLRR-1 expression. Yellow arrows indicate the somite where
dorsal NLRR-1, Myf5 and Mrf4 expression initiate. Note that Mrf4 expression initiates later (I).
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protein–protein interaction domains and a short intracellular
tail (Fig. 6C).
The NLRR-2 cDNA showed 85% identity at the DNA
level and 87% identity at the amino acid level to the human
GAC1 gene, indicating that NLRR-2 is the mouse homo-
logue of GAC1 (Table 2). Comparison of the intracellular
domains of NLRR-2 and GAC1 showed conservation of a
sequence with high similarity to the consensus sequence of a
WW domain, a well-characterised protein–protein interac-
tion motif (Fig. 6A) (Macias et al., 2002; Sudol, 1996).
Alignment of the intracellular domains of NLRR-1 andNLRR-3 highlights a stretch of conserved amino acids
(ELYPPLINLWE), also conserved in NLRR proteins from
Xenopus (Fig. 6B), rat (Fukamachi et al., 2001) and
zebrafish (Bormann et al., 1999), that are not present in
NLRR-2. This sequence is similar to a clathrin adapter
interaction motif and has been shown to mediate interaction
with clathrin via a-adaptin in the case of rat NLRR-3
(Fukamachi et al., 2002).
Recently, human NLRR-1 and NLRR-3 cDNAs have
been reported (Hamano et al., 2004) and comparison
between the mouse and human genomes showed that
NLRR-1 and NLRR-3 genes exist in the human. The human
Fig. 4. Expression of NLRR-1 during Xenopus development. Whole-mount in situ hybridisation of Xenopus laevis embryos with a riboprobe for XNLRR-1. (A)
stage 13, (B) 16, (C) 18, (D) 20, (E) 24, (F) 27, (G) 30. A–C are dorsal views while D–G are lateral views. All embryos are arranged with anterior to the right.
The arrowhead indicates earliest expression in the anterior neural plate. Expression in the chevron-shaped somites is clearly visible.
B.P. Haines et al. / Developmental Biology 281 (2005) 145–159152NLRR-1 gene is present on chromosome 3 (called LRRN1/
KIAA1497) and its predicted protein sequence showed 96%
identity to mouse NLRR-1 (Table 2). The human NLRR-3
gene is present on chromosome 7 (LRRN3/FLJ11129), with
a predicted protein sequence identity of 88%. The GAC1Fig. 5. Comparison of the protein sequences of the murine NLRR family members.
and NLRR-3. Identical residues are boxed. The 12 conserved leucine repeats are
sequences are indicated by asterisks. Conserved residues of predicted Ig loop (CC
domains are underlined by a dashed line. The cytoplasmic tail domain conservedgene, the human homologue of NLRR-2, is present on
chromosome 1. No further genes with the 12 leucine-rich
repeat, single fibronectin domain and immunoglobulin
domain structure of the NLRRs were found in the human
or mouse genomes, confirming the NLRR genes as a three-Murine NLRR-2 protein sequence is aligned with the sequences of NLRR-1
underlined. Conserved cysteine residues in the C- and N-terminal flanking
) and FNIII (WY) domains are boxed. Signal sequence and transmembrane
between NLRR-1 and NLRR-3 is double underlined.
Fig. 6. NLRR proteins contain intracellular protein–protein interaction domains. (A) Comparison of the cytoplasmic domains of mouse NLRR-2 and human
GAC1. Conserved tryptophan residues of a putative WW domain are boxed and conserved proline/leucine residues upstream of the first tryptophan are
underlined. (B) Comparison of the intracellular domains of mouse, human and Xenopus NLRR-1 and mouse and human NLRR-3. The conserved clathrin
adapter interaction domain is underlined. (C) Schematic diagram of the three member NLRR protein family and their closest Drosophila relatives Capricious
and Tartan. SS—signal sequence; NFR—N-terminal flanking sequence; LRR—leucine-rich repeat; CFR—C-terminal flanking sequence; Ig—C2-type Ig-like
domain; FN—fibronectin type III domain; TM—transmembrane domain; WW—WW domain; Cl—clathrin adapter interaction domain.
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a NLRR-5 gene but sequence comparison shows that NLRR-
5 lacks the fibronectin domain characteristic of the other
NLRRs. Three other similar genes exist in the mammalian
genome (Carim-Todd et al., 2003), indicating that NLRR-5 is
a member of a separate gene family and should be renamed.
Other gene families, like the FLRTs and LRRTMs, encode
transmembrane proteins with extracellular leucine-rich
repeats but which contain different combinations of addi-
tional domains (Lacy et al., 1999; Lauren et al., 2003). The
NLRR genes all exhibit a similar genomic structure with theTable 2
Percentage of amino acid identity between mouse, human and Xenopus NLRR p
NLRR1 NLRR2 NLRR3
NLRR1 100 46 51
NLRR2 100 45
NLRR3 100
hNLRR1
hNLRR2
hNLRR3
XNLRR1
Note. Human (h) NLRR-1 and NLRR-3 protein sequences were translated fromentire open reading frame and 3V-untranslated region plus
some 5V-untranslated sequence located within a single large
exon, with one or two small exons upstream containing
additional 5V-untranslated sequence.
BLAST searching of the entire Drosophila genome
showed that two genes, Tartan and Capricious, exhibited
the highest similarity to the NLRRs throughout the LRR
sequence: they also have a predicted secondary structure
containing external LRRs with cysteine flanking sequences,
a transmembrane domain and short intracellular tails (Fig.
6C). Furthermore, these genes showed a similar genomicroteins
hNLRR1 hNLRR2 hNLRR3 XNLRR1
96 47 51 79
47 87 45 45
52 46 88 51
100 47 53 79
100 46 46
100 51
100
the human genome sequence. hNLRR-2 and human GAC1 are identical.
B.P. Haines et al. / Developmental Biology 281 (2005) 145–159154structure with the entire coding sequence existing in a
single exon with further upstream exons containing addi-
tional 5V-untranslated sequence (Milan et al., 2001). No
genes with this structure which encode proteins of the same
predicted secondary structure were found in the genome of
C. elegans.
Expression of other NLRR genes during mouse development
To examine the expression of the other NLRR genes in
more detail, we performed whole-mount in situ hybrid-
isation throughout mouse embryogenesis. Analysis of
NLRR-3 at 10.5 dpc showed strong expression in the
trigeminal and facio-acoustic ganglia and in the migrating
germ cells in the tail (Figs. 7A and Ai). Lower levels of
expression were also present in the dorsal root ganglia,
neural tube, hindbrain and eye (Figs. 7A and Ai–iii).
Transverse sections through the trunk revealed that expres-
sion in the neural tube was restricted to the developing
motor horn (Fig. 7Ai). Expression in the hindbrain was
restricted to a subregion in the outer edge of the neural
tissue (Fig. 7Aii). Further small domains of expression are
found in the head associated with the olfactory system and
in the outer extremities of the optic cup (Figs. 7Aii–iv).Fig. 7. Expression of NLRR-3 during mouse development. (A) Whole-mount in
embryo in Awith the approximate plane of section shown by yellow lines. (B) Who
plane of section of Bi and iii is shown by yellow lines. The arrow in Bi indicates
small patch of NLRR-3 expression within the brain is highlighted by the arrowhea
acoustic ganglia; gc—germ cells; mh—motor horn; ob—olfactory bulb; oc—optic
post coitum.NLRR-3 expression was also detected in the trigeminal
and facio-acoustic ganglia at 9.5 dpc (Figs. 7B and Biii).
Sections revealed further expression in the motor horn of the
neural tube (Fig. 7Bi) and in a small domain within the brain
(Fig. 7Biii, arrowhead), which is also visible in a
longitudinal section through the head (Fig. 7Bii, arrow-
head). Non-neural expression was detected in the lens
placode (Fig. 7Biii) and the migrating germ cells in the tail
(Fig. 7B).
We were unable to detect NLRR-2 expression in mouse
embryos by whole-mount in situ hybridisation. NLRR-2 is
expressed at much lower levels in early development than
NLRR-1 and NLRR-3 by radioactive in situ hybridisation,
Northern blot and PCR (Taguchi et al., 1996; data not
shown).
Expression of NLRR mRNAs in the adult
The identification of extra sites of expression during
development prompted further examination of NLRR
expression in adult tissues. Strong expression of an ~4.4-
kb NLRR-1 mRNA was detected in the brain, as previously
reported (Taguchi et al., 1996), and also in the kidney with
lower levels in spleen, lung, muscle and testis (Fig. 8). Forsitu hybridisation of a 10.5 dpc mouse embryo. Ai–iv are sections of the
le-mount in situ hybridisation of a 9.5 dpc mouse embryo. The approximate
expression in the motor horn. Bii is a longitudinal bisection of the head. A
d in Bii and iii. drg—dorsal root ganglia; tg—trigeminal ganglia; fa—facio-
cup; hb—hindbrain; lp—lens placode. Numbers in A and B indicate days
Fig. 8. NLRR gene expression in adult mouse tissues. A filter carrying adult
mouse tissue mRNA was hybridised with cDNA probes for NLRR-1,
NLRR-2, NLRR-3 and human b-actin. A single band was detected for each
NLRR gene.
B.P. Haines et al. / Developmental Biology 281 (2005) 145–159 155NLRR-2, strong expression of an ~4.3-kb mRNA was
detected in brain with low levels in the heart, lung, liver
and testis. An NLRR-3 mRNA of ~4.4 kb was also
expressed highly in brain and at lower levels in lung, asFig. 9. Cellular localisation of NLRR proteins. (A) Immunohistochemical staining o
NLRR-2 and NLRR-3 proteins, and costained with the endoplasmic reticulum ma
protein and the endoplasmic reticulum marker. Red staining cells are untransfecte
extracts from transfected Cos-7 cells incubated with (+) or without () tunicamy
transfected with pCDNA3.1 expression vector. Background bands in the controlpreviously reported (Taniguchi et al., 1996), and was also
found in liver and kidney.
Cellular localisation of NLRR proteins
From the predicted protein secondary structure, it was
postulated that NLRR proteins are localised to the cell
membrane and possibly are involved in cell adhesion and/or
signalling. To examine the cellular localisation of the NLRR
proteins, cDNAs were constructed encoding NLRR open
reading frames containing C-terminal FLAG-tags. These
NLRR cDNAs were transiently transfected into Cos-7 cells
and protein localisation visualised by staining with anti-
FLAG monoclonal antibody and fluorescein-conjugated
secondary antibody. 3VFLAG-tagged NLRR proteins were
localised to the endoplasmic reticulum/golgi pathway when
overexpressed in Cos cells which was confirmed by
costaining with the endoplasmic reticulum marker conca-
navalin A (Fig. 9A).
Many membrane proteins that are involved in protein–
protein interaction are known to be glycosylated, and
glycosylation is important for their function. Western blots
of protein extracts from cells transfected with NLRR-1,
NLRR-2 and NLRR-3 all showed the presence of protein
bands that were reduced in molecular weight by treatment
with the N-linked glycosylation inhibitor tunicamycin (Fig.
9B). NLRR-1 showed a major band of ~95 kDa which was
reduced to a band of ~75 kDa, NLRR-2 showed a major
band of ~75 kDa which was reduced to a band of ~70 kDa,
while NLRR-3 showed a major band of ~85 kDa that wasf Cos-7 cells transfected with plasmids encoding 3VFLAG-tagged NLRR-1,
rker concanavalin A. Yellow fluorescence indicates colocalisation of NLRR
d cells that stain positive for concanavalin A only. (B) Western blot of cell
cin. Size of protein molecular weight standards is shown. Control is cells
are due to non-specific binding of the anti-FLAG antibody.
B.P. Haines et al. / Developmental Biology 281 (2005) 145–159156reduced to ~72 kDa. These data show that NLRR proteins
can localise to the endoplasmic reticulum for transport to the
cell membrane and are glycosylated during this process.Discussion
Analysis of differential gene expression in the early
mouse embryo is limited by the small amount of material
available and the technically demanding dissections
required for the isolation of distinct tissue samples. mRNA
differential display (Liang and Pardee, 1992) provides a
potentially useful technology for analysing differential gene
expression where very little tissue is available. However, the
only practical and informative secondary screen in the
mouse embryo, that of whole-mount in situ hybridisation, is
problematic due to the unreliability of riboprobes made from
the short products typically generated from conventional
ddPCR (Gupta et al., 1998). We have developed a modified
technique for differential display PCR, involving the low
stringency binding of a single longer arbitrary primer, that
yields display products of a larger size which reliably
provide much more useful templates for the production of
riboprobes. We found that approximately half the PCR
products obtained using this method produced useful in situ
probes compared with approximately one in ten using
conventional differential display PCR. This technique could
be applied to any developmental system where the amount
of tissue is limiting particularly for differential gene analysis
between tissues that need to be isolated by dissection. The
sequencing of animal genomes and the wealth of EST
sequence data available increase the amount of information
that can be obtained from this sort of analysis. Further
cDNA sequences can be easily identified and isolated for
use as in situ probes for those ddPCR products that do not
yield effective probes. Identification of full-length sequen-
ces can be rapidly performed and analysis of many different
ddPCR products carried out quickly with known or
unknown genes of particular interest selected for further
analysis.
Using this technique, we identified six genes the differ-
ential display profile of which was confirmed by analysis of
their gene expression by in situ hybridisation. The isolation
of Sp5 as a presomitic mesoderm specific gene (Harrison et
al., 2000) confirmed the reliability of the technique. Two
genes, dynein intermediate chain 1 and reticulon 1, were
isolated that showed somite specific differential display
patterns but are expressed in the dorsal root ganglia
(Crackower et al., 1999; Fig. 2B). These ganglia migrate
through the early somites and cannot be separated by
dissection highlighting that the major limitation of this
technique lies in the dissection and not the molecular
biological procedures. The NLRR-1 gene product was
isolated as a somite specific transcript which highlights
the usefulness of this method in identifying novel sites of
expression of previously characterised genes. Similarly,connexin43 was shown to be expressed in the presomitic
mesoderm, a site of expression that had not been previously
described. Txndc5 is a novel gene expressed in somites the
expression pattern of which had not been previously
reported. These results show the different types of genes
that can be isolated from this screen with the utilisation of in
situ hybridisation as a secondary screen allowing the rapid
and precise localisation of the sites of gene expression
within the developing embryo.
NLRR-1 was previously cloned from a mouse brain
cDNA library and shown by Northern blot and radioactive
in situ hybridisation to be expressed in the adult brain and
the developing embryonic neural system. This is in agree-
ment with the localisation in the forebrain, hindbrain and
neural tube by whole-mount in situ hybridisation presented
here (Fig. 2B). Recently, NLRR-1 was isolated in a screen
for somite specific signal sequence containing molecules in
the chick (Tonegawa et al., 2003), and as a neural expressed
gene in the mouse (Aubert et al., 2003) and was shown to be
expressed in somites by in situ hybridisation. Our more
detailed analyses have revealed that somitic expression in
the mouse is localised to myoblasts of the developing
myotome, and that additional sites of expression occur in
myoblasts in the branchial arches, hypoglossal chord and
limbs, as well as non-muscle cells in the eye. Somitic
expression follows myoblast formation and movement from
the dorsal lip of the dermomyotome into the developing
myotome, identifying it as an early response gene in
myoblast differentiation. NLRR-1 expression closely resem-
bles the dorsal expression domain of the myoblast determi-
nation gene Myf5, which may indicate that it is a very early
transcriptional target of Myf5 or that it is controlled by the
same environmental signals as Myf5. However, no NLRR-1
expression is seen in the ventral lip of the somite, the
somitic bud, where Myf5 and Mrf4 expression are seen in
the dermomyotome and myotome (Summerbell et al., 2000,
2002), indicating that NLRR-1 identifies a subset of
myotomal precursors. Expression of NLRR-1 during somite
development in the chick appears first in the presegmental
plate and is already on strongly in the dermomyotome of
each somite as it is born, only later does it extend weakly to
the myotome (Tonegawa et al., 2003). This correlates with
the expression of the chick Myf5 gene which is also
expressed initially in the presegmental plate, then in the
epithelial somite and only later in the dorsal dermomyotome
and myotome identifying a consistent relationship between
these two genes in these species. These differences may in
part relate to differences in somite development and muscle
formation between chick and mouse such as the transient
nature of the epithelial sphere of the earliest somites in the
mouse (Hirsinger et al., 2001; Kiefer and Hauschka, 2001).
Analysis of Xenopus NLRR-1 demonstrated expression in
similar developmental regions to the mouse including the
somites (Fig. 4B). The majority of the Xenopus somite is
comprised of muscle cells indicating that myoblast-specific
expression is conserved through vertebrate evolution. In the
B.P. Haines et al. / Developmental Biology 281 (2005) 145–159 157mouse, NLRR-3 is expressed in ganglia with further
expression in the eye, motor neurons and the migrating
germ cells. NLRR expression in the adult is strongest in the
brain but occurs in several other tissues. The expression of
NLRRs in non-neural tissues indicates that their function
may not be neural specific as previously suggested but more
central to cell biology and development, although the
possibility of a role in formation of neural contacts with
these other tissues cannot be ruled out.
The mouse NLRR gene family was initially reported as
two full-length sequences and a partial cDNA expressed in
the mouse brain and developing nervous system (Taguchi et
al., 1996; Taniguchi et al., 1996). Subsequently, the full-
length cDNA of NLRR-2, the mouse homologue of the
human GAC1 gene, was cloned by us and others completing
the NLRR gene family in the mouse. Analysis of the entire
mouse and human genomes showed no other genes
exhibiting the characteristic NLRR secondary structure
indicating that NLRR genes constitute a three-member
mammalian gene family. Human cDNAs for the three-
member NLRR family have recently been described
(Hamano et al., 2004). NLRR genes were subsequently
cloned in Xenopus, zebrafish and rat (Bormann et al., 1999;
Fukamachi et al., 2001; Hayata et al., 1998). The predicted
protein secondary structure indicates that they encode
transmembrane proteins carrying 12 extracellular leucine-
rich repeats surrounded by amino- and carboxy-terminal
flanking regions, a fibronectin type III domain and an
immunoglobulin-like C2 domain, together with a short
intracellular tail (Hayata et al., 1998) implying a role in
modulating cell adhesion or signalling at the cell surface.
Analysis of the Drosophila genome showed the genes
Capricious and Tartan, which were most closely related to
the NLRRs through the leucine-rich repeats, exhibited a
similar predicted secondary structure. The NLRR genes also
exhibit a conserved exon structure both between family
members and between species, with the entire ORF, the 3V
UTR and some 5VUTR being contained within one large
exon with further small upstream exons containing addi-
tional 5V UTR sequences. Tartan and Capricious also
exhibit this genomic structure, suggesting that they may
be evolutionarily related. Several other families of leucine-
rich repeat membrane proteins have been described that
contain multiple members of identical secondary structure
that are likely to arise from a common evolutionary origin
(Carim-Todd et al., 2003; Kuja-Panula et al., 2003; Lacy et
al., 1999; Lauren et al., 2003). The NLRR-5 gene reported
by Hamano et al. (2004) encodes a protein with a different
secondary structure to the NLRRs and examination of the
mammalian databases indicates that it is a member of a
separate gene family (Carim-Todd et al., 2003). The
functions of these genes are unknown but their duplication
through evolution indicates that these proteins are likely to
have important biological roles.
Leucine-rich repeats (LRRs) are a conserved hydro-
phobic repeat structure of approximately 24 amino acidsthat mediates protein–protein interactions and are found in
proteins of diverse function and cellular location (Kobe and
Deisenhofer, 1995). Recent advances in the understanding
of LRR structure have shown that the repeated leucine
motifs form a structural framework that provides a concave
molecular surface for protein binding (Kobe and Kajava,
2001). Many membrane-localised proteins contain LRRs in
their extracellular regions, suggesting that these motifs may
be involved in mediating cell adhesion or signalling through
interactions with surrounding cells, the extracellular matrix
or extracellular ligands (Buchanan and Gay, 1996). The
short intracellular tails of NLRR-1 and NLRR-3 contain a
conserved clathrin adapter interaction domain (Fukamachi
et al., 2002). Whether interaction with the clathrin machi-
nery is a mechanism for regulating NLRRs at the cell
surface or a mechanism for eliciting their function is
unknown but it provides an intracellular basis for NLRR
function inside the cell. The presence of a WW domain in
NLRR-2/GAC1 instead of a clathrin interaction domain is
provocative. WW domains are well-characterised protein–
protein interaction motifs which suggests that the NLRRs
can provide a link between the extracellular and intracellular
environment via protein–protein interaction through their
various domains. This domain could mediate clathrin
interaction via an alternate mechanism or may specify
NLRR-2 to a different intracellular function. NLRR-2 was
isolated from somite tissue and is expressed at a much lower
level in the embryo, which may indicate an alternate
function to the other NLRRs, although without precise
tissue-specific localisation, this can only be speculation.
This low embryonic expression may explain its identifica-
tion as a gene associated with human glioma (Almeida et al.,
1998) with a defect caused by overexpression of this gene
manifesting itself only in the fully developed organism.
Being located at the cell membrane and able to interact
with extracellular proteins and the intracellular protein
trafficking machinery provides a mechanism for NLRRs
to affect cell adhesion. However, recent data suggest that
these proteins may be involved in the regulation of cell
signalling. Fukamachi et al. (2002) showed that rat NLRR-3
may be involved in the regulation of EGF receptor signal-
ling through the clathrin binding endocytosis motif in the
cytoplasmic tail. XFLRT3, a protein with a similar
secondary structure to NLRRs, has been shown to interact
with and modulate FGF signalling pathways with its
intracellular region being capable of affecting signalling
(Bottcher et al., 2004). Furthermore, the structurally similar
vasorin protein has been shown to interact with and regulate
the cellular response to TGF h (Ikeda et al., 2004).
Therefore, we suggest that NLRRs do not simply have the
capacity to regulate cell adhesion by protein–protein
interaction but may act in response to environmental cues
and bring about changes at the transcription level by
regulating cell signalling pathways. The identification of
protein interaction partners for both the LRR domains and
the intracellular tail will elucidate the mechanism by which
B.P. Haines et al. / Developmental Biology 281 (2005) 145–159158these proteins operate and provide further insight into their
biological function.Acknowledgments
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